Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine

Vaccine

Volumn 23, Issue 34, 2005, Pages 4353-4358

  Pereira, Alexandre ^a   Pietro Pereira, Aparecida Santo ^a   Moreira Filho, Carlos A ^b   Bando, Sylvia Y ^b   Tambourgi, Denise V ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bordetella pertussis; Strains; Whole cell pertussis vaccine

Indexed keywords

BACTERIAL DNA; PERTUSSIS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOLOGICAL TRAIT; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HUMAN; IMMUNOGENICITY; IMMUNOLOGY; NONHUMAN; PERTUSSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; RANDOM AMPLIFIED POLYMORPHIC DNA; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; ELECTROPHORESIS; HUMANS; IMMUNOBLOTTING; MICE; PERTUSSIS VACCINE; RABBITS;

EID: 22244443658     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.03.033     Document Type: Article

References (27)

1. Annual report 2000. Vaccines and Biologicals. Geneva, Switzerland: World Health Organization; 2001 (WHO/V&B/01.01).
2. S.P. Cordova, M.T. Giles, and M.Y. Beers The outbreak that had to happen: Bordetella pertussis in north-western Australia in 1999 Commun Dis Intell 24 2000 375 379
3. S.E. Neppelenbroek, H.E. De Melker, J.F. Schellekens, and M.A. Corryn-Spaendock The incidence of pertussis in The Netherlands has remained high since an outbreak occurred in 1996 Euro Surveill 4 1999 133 134
4. Pertussis vaccines. World Health Organization position paper. Weekly Epidemiol Rec 1999;74:137-43.
5. M.P. Préziosi, A. Yam, S.G.F. Wassilak, L. Chabirand, A. Simaga, and M. Ndiaye Epidemiology of whooping cough in a West African community before and after introduction of a widespread vaccination program Am J Epidemiol 155 2002 891 896
6. J.W. Bass, and S.R. Stephnson The return of pertussis Pediatr Infect Dis J 6 1987 141 144
7. R.J.L. Willems, and F.R. Mooi From whole-cell to acellular vaccine Rev Med Microbiol 7 1996 13 21
8. I.H.M. van Loo, G.J. van der Heide, N.J.D. Nagelkerke, J. Verhoef, and F.R. Mooi Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population J Infect Dis 179 1999 915 923
9. H.E. De Melker, M.A. Conyn-van Spaendonck, H.C. Rumke, J.K. van Wijingaarden, F.R. Mooi, and J.F. Sehellekens Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine Emerg Infect Dis 3 1997 175 178
10. World Health Organization Expert Committee on Biological Standardization: 40th report, Geneva: World Health Organization (WHO technical report series, no. 800), Annex 2., 1990.
11. J. Bordet, and O. Gengou Le microbe de la coqueluche Ann Inst Pasteur 20 1906 731 741
12. D.W. Stainer, and M.J. Scholte A simple chemically defined medium for the production of phase I Bordetella pertussis J Gen Microbiol 63 1970 211 220
13. E. Njamkepo, F. Rimlinger, S. Thiberge, and N. Guiso Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity Vaccine 20 2002 1290 1294
14. A.J. Mileham Identification of microorganisms using random primed PCR Mol Biotechnol 8 1997 139 145
15. R.S. Ronimus, L.E. Parker, and H.W. Morgam The utilization of RAPD-PCR for identifying thermophilic and mesophilic Bacillus species FEMS Microbiol Lett 147 1997 75 79
16. A. Di Tommaso, M. Bartalini, S. Peppoloni, A. Podda, R. Rappuoli, and M.T. De Magistris Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults Vaccine 15 11 1997 1218 1224
17. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
18. C.M. Tsai, and C.E. Frasch A sensitive silver stain for detecting lipopolysacchrides in polyacrylamide gels Anal Biochem 119 1982 115 119
19. H. Towbin, T. Staehelin, and J. Gordon Eletrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci 76 1979 4350 4354
20. A. Pereira, A.S.P. Pereira, M.A. Sakauchi, R.F.C. Rossetti, and I. Raw The use of frozen inoculum and 0.2% formaldehyde for inactivation of pertussis vaccine production Rev Farm Bioquím Univ São Paulo 31 1995 85 88
21. M. Pittman, and B.C. Cox Pertussis vaccine testing for freedom from toxicity Appl Microbiol 13 1965 447 456
22. J.D. van Ramshorst Toxicity control of pertussis vaccine by the mouse weight gain test Prog Immunobiol Stand N Y 3 1969 324 326
23. S.I. Morse, and J.M. Morse Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis J Exp Med 143 1976 1482 1502
24. J.J. Munoz, H. Arai, and R.L. Cole Mouse-protecting and histamine - sensitising activities of pertussis and fimbrial hemaglutinin from Bordetella pertussis Infect Immun, Washington 32 1981 243 250
25. P. Kendrick, G. Eldering, M.N. Dixon, and J. Misher Mouse protection test in study of pertussis vaccine: comparative series using intracerebral rout for challenge Am J Public Health 37 1947 803 910
26. World Health Organization. Informal consultation on the control of pertussis with whole-cell and acellular vaccines. World Health Organization report WHO/V&B/99.03, Geneva, Switzerland: World Health Organization; 1999.
27. Editorial, pertussis: adults, infants, and herds. Lancet 1992;339:526-7.